New HCPCS Code Descriptor for J1954 Cipla USA’s LEUPROLIDE ACETATE INJECTION DEPOT – 3/14/23

Effective April 1, 2023: J1954 New HCPCS Code Descriptor for Cipla USA's LEUPROLIDE ACETATE INJECTION DEPOT (Leuprolide Acetate for Depot Suspension)
 

Effective April 1, 2023:


New HCPCS Code Descriptor for J1954: Injection, leuprolide acetate for depot suspension (cipla), 7.5 mg.


J1954 is a unique HCPCS code for Cipla's version of LEUPROLIDE ACETATE INJECTION DEPOT (Leuprolide Acetate for Depot Suspension) and should not be used for billing other leuprolide formulations.

HCPCS

Code

HCPCS Code

Descriptor

NDC

Number

Strength

WAC Per Package

HCPCS Units Per Package

J1954

Injection, leuprolide acetate for depot suspension (cipla), 7.5 mg

69097-0909-50

22.5 mg

$1,355.07

3

We respectfully request the update of all claims and reimbursement systems to include the new HCPCS code descriptor for J1954: Injection, leuprolide acetate for depot suspension (cipla), 7.5 mg.

effective April 1, 2023


Please contact us @ Account.Management@Cipla.com

 


© Copyright 2023 Cipla USA Inc. All rights reserved


April 2023   CUSAI-4012023-x